Improvement in atrophic acne scars using topical synthetic Epidermal Growth Factor (EGF) serum: A pilot study

Journal of Drugs in Dermatology

Volumn 14, Issue 9, 2015, Pages 105-1010

  Seidel, Rachel ^a   Moy, Ronald L ^b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Moy Fincher Chipps Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA REGENERATION SERUM; EPIDERMAL GROWTH FACTOR;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GOODMAN GRADE; HUMAN; INVESTIGATOR GLOBAL ASSESSMENT; MALE; MEDICAL PHOTOGRAPHY; PATIENT ATTITUDE; SCAR; SELF EVALUATION; SERUM; SKIN ATROPHY; SKIN DISEASE ASSESSMENT; ACNE VULGARIS; ATROPHY; CICATRIX; COMPLICATION; FACIAL DERMATOSES; MIDDLE AGED; PATHOLOGY; PHOTOGRAPHY; PILOT STUDY; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADULT; ATROPHY; CICATRIX; EPIDERMAL GROWTH FACTOR; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOGRAPHY; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84976334314     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001; 45: 109–117
2. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring nd its incidence. Clin Exp Dermatol. 1994;19:303-8
3. Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50–57.
4. Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol. 2001;2:135–141.
5. Goodman GJ. Post-acne scarring: a short-review of its pathophysiology. Australas J Dermatol.2001;42(2):84-90.
6. Fabbrocini G, Vita VD, Cozzolino A, et al. Management of atrophic acne scars: overview and new tools. J Clin Exp Dermatol. Res S5:001.
7. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, et al. (2005) Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 166:1691–1699
8. Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: Experience with 961 treatments. Dermatol Surg. 2008;34:301–7.
9. Rivera A. Acne scarring: A review of current treatment modalities. J Am Acad Dermatol. 2008;59:659–76.
10. Harris DWS, Buckey CC, Ostlere LS, Rustin MHA. Topical retinoic acid in the treatment of fine acne scarring.Br J Dermatol. 1991;125:81–82.
11. Fabbrocini G, Annunziata MC, D’Arco V, et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract.2010;2010:893080
12. Schmidt JB, Donath P, Hannes J, Perl S, Neumayer R, Reiner A. Tretinoin – iontophoresis in atrophic acne scars. Int J Dermatol.1999; 38: 149–153
13. Goodman GJ, Baron JA. Post acne scarring: A qualitative global scarring grading system. Dermatol Surg. 2006;32:1458–66.
14. Sadove R. Injectable poly-L-lactate acid: a novel sculpting agent for treatment of dermal fat atrophy after severe acne. Aesth Plast Surg. 2009;33:113–116
15. Holland DB, Jeremy AH, Roberts SG, Seukaran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: A Comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol.2004;150:72–81.
16. Schouest JM, Luu TK, Moy RL. Improved texture and appearance of human facial skin after daily topical application of barley-produced, synthetic, human0like epidermal growth factor (EGF) serum_J Drugs Dermatol.2012;11(5):613-20.
17. Midgley AC, Rogers M, Hallett MB, et al. Transforming growth factor-?1 (TGF-?1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. Journal of Biological Chemistry. 2013;288(21):14824–14838.
18. Lee WJ, Jung HJ, Lim HJ, et al. Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities._J Eur Acad Dermatol Venereol. 2013;27(5):643-6.
19. Walia S and Alster T. Prolonged clinical and histological effects from CO2 laser resurfacing of atrophic acne scarring. Dermatol Surg. 1999; 25: 926–930.
20. Garg S, Bajeva S. Combination therapy in the management of atrophic acne scars._J Cutan Aesthet Surg. 2014 Jan;7(1):18-23.
21. Jensen K.B., Collins C.A., Nascimento E., Tan D.W., Frye M., Itami S., Watt F.M. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell. 2009;4:427–439.
22. Brown GL, Curtsinger L, 3rd, Brightwell JR, et al. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med. 1986;163(5):1319-1324.
23. Laato M, Kähäri VM, Niinikoski J, Vuorio E. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem J. 1987;247:385-8.
24. Nanney LB. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol. 1990;94(5):624–629.
25. Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging state of the art. Ann N.Y. Acad Sci. 2007;1119:40–50.
26. Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol. 1992;18(7):604–606.
27. Dong KK, Damaghi N, PIcart SD et al. UV-induced DNA damage initiates release of MMP-1 in human skin. Exp Dermatol._2008;17(12):1037-44.